Angiogenesis

Antiangiogenesis therapy is a new form of lung cancer treatment that is currently being tested in clinical trials. Antiangiogenesis is designed to combat lung cancer by preventing angiogenesis with angiogenesis inhibitors.

What is Angiogenesis?

Angiogenesis is the formation of new blood vessels in the body. Angiogenesis is regulated by a particular set of chemicals. All cells-including cancerous cells-need to feed off these vessels so they may grow and replicate. If the cells lose access to these new blood cells (in this case, as a result of angiogenesis inhibitors), they'll shrink and eventually die.

Antiangiogenesis halts the growth of new blood vessels off which cancerous tumors feed by using a combination of strong drugs called angiogenesis inhibitors. By cutting off tumors' blood supplies, angiogenesis inhibitors ultimately kill the tumors.

Side Effects of Angiogenesis

Side effects of angiogenesis inhibitors are believed to be much milder than those of other lung cancer treatments, including lung cancer surgery, radiation therapy, photodynamic therapy, and chemotherapy.

Angiogenesis Success Rates

Although the outlook for antiangiogenesis' success is good, there are still some kinks to work out. For example, the effectiveness of antiangiogenesis in humans is not fully understood. In addition, researchers still don't know if undetected tumors can be treated with angiogenesis inhibitors, nor do they know the long-term effects of angiogenesis inhibitors on the body.

Locate a Lung Cancer Attorney in Your Area

If you or someone you love has developed lung cancer and is currently undergoing treatment, it is important for you to speak with a lung cancer lawyer to learn about your legal options. Use our legal directory to find a lung cancer lawyer in your state.